One of the country's largest providers of private Medicare plans saw its stock sink to its lowest level in 15 years after the federal government cut the rating for one of its most popular offerings.

Humana Inc.’s stock closed down another 1.9% on Thursday to bring its week-to-date losses to 24.3%, after BofA Securities ...

EVgo stock surges after the company receives a $1 billion Energy Department loan commitment, Levi Strauss tumbles after ...

The biggest retailers were zealous in their pursuit of home-based health care initiatives. But there’s little evidence to ...

The first choice to make during open enrollment is whether to enroll in traditional Medicare with a Medigap plan or a Medicare Advantage plan. That may be a head-scratcher for some; a survey by the ...

Annual National Conference was held Sep. 4-6 in Orlando, Florida. Managed Healthcare Executive is the official publication of ...

Humana Inc.'s stock slid another 2.5% Thursday to bring its week-to-date losses to 24.4%, after BofA Securities downgraded it to underperform - or sell - on concerns about a delay in margin recovery.

The S&P 500 Index ( $SPX) ( SPY) today is down by -0.38%, the Dow Jones Industrials Index ( $DOWI ) ( DIA) is down by -0.66%, and the Nasdaq 100 Index ( $IUXX) ( QQQ) is down by -0.25%.

Only 25% of Humana members will be in plans with four stars or above next year, down from 94% this year, the insurer ...

周四，尽管面临美国医疗保险和医疗补助服务中心（CMS）对其计划评级的挑战，Raymond James仍维持Humana Inc.（NYSE:HUM）股票的"市场表现"评级。该公司股价在初始下跌后略有回升，交易价格为247美元，较近期高点大幅下跌。 Humana的管理层召开电话会议，讨论了他们正在进行的对CMS上诉可能产生的影响。此次上诉旨在解决Medicare Advantage（MA）计划评级中 ...

How supplies of GLP-1 drugs could be at risk as a result of the dockworker strike occurring across the East and Gulf coasts: ...

在其他近期新闻中，Humana Inc.出现了重大发展。根据伯恩斯坦的分析，该健康保险公司2025年的Medicare Advantage产品因定价策略问题引发市场担忧。此外，Humana的Medicare星级评级出现戏剧性下降，4星以上计划的成员比例从94%降至仅25%。这主要归因于Humana的H5216合同（约占Humana Medicare ...